Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- (-) Biopharmaceutical Innovation
- (-) Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- (-) Health Spending
- Health Spend Management
- High-Deductible Health Plans
- (-) Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- (-) Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Audience
Display Only
Showing 182 Results
NPC in Chain Drug Review: Preserving the Proven Impact of Biopharmaceutical Innovation
In his latest commentary for Chain Drug Review, NPC President and Chief Executive Officer Dan Leonard considers the challenges in measuring and paying for value in health care, particularly when it…
Going Below the Surface E-newsletter: August 2018
In this issue, we share a video with experts on the importance of understanding health care spending, why patient engagement matters, and more on value-based care.
Going Below the Surface: A Video on Why We Need to Have a Health Spending Dialogue
Watch health care experts explain why it's important to find tangible solutions to inefficiencies in the American health care system.
Going Below the Surface E-newsletter: July 2018
In this issue, we explore spending on end of life care and Medicare and Medicaid spending.
Controlling Health Care Costs Means Confronting Misconceptions
The only way that we can begin to reduce overspending on health care is if we base decisions on what the evidence indicates.
NPC in Specialty Pharmacy Times: Going Below the Headlines on Health Spending in Four Steps
In his latest commentary for Specialty Pharmacy Times, NPC President Dan Leonard offers four suggestions to reconsider how we assess, analyze and apply the evidence and data around health spending to…
National Pharmaceutical Council and Anthem Support Health Affairs in Launching New Council on Health Care Spending and Value
NPC launched a broader stakeholder initiative funding research and supporting a series of papers and blog posts in Health Affairs last December. It is in service of this broader mission that NPC,…
NPC in Morning Consult: Does High Return Call for Greater Investment?
In his latest commentary for Morning Consult, NPC Chief Science Officer Robert W. Dubois explores new research that sheds light on which types of medical care have provided the greatest overall…
Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?
An article published on the Health Affairs Blog explores the tensions with paying for gene therapies via online market research with payers and highlights a few proposals to address these concerns.
The Effect of Medical Technology Innovations on Patient Outcomes, 1990-2015: Results of a Physician Survey
A survey published in the Journal of Managed Care & Specialty Pharmacy of U.S. physicians provides insight on their perceptions regarding which medical innovation has impacted outcomes the most…
Survey Data Shows Physicians See Pharmaceuticals as Leading Contributor to Improved Health Outcomes
Research by RTI Health Solutions and the National Pharmaceutical Council shows the value of biopharmaceutical and pharmaceutical innovations to improving patient health.
Context Matters on Health Statistics
A single number doesn’t always tell the full story, and that’s the case when it comes to a recent report from AHIP asking how our health care premium dollars are being spent.
FDA Clarifies What Information Can Be Exchanged With Health Decision-Makers
With the release of two guidance documents this week, the US Food and Drug Administration took significant steps to modernize how health care information is communicated. The final guidance released…
High Spending Growth Rates For Key Diseases Were Driven By Technology And Demographic Factors
Research published in the June 2018 edition of Health Affairs shows that increases in health care spending on key diseases can be attributed to several factors: the use of new and often…